Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining

Tsang Pai Liu, Yao Yu Hsieh, Chia Jung Chou, Pei Ming Yang

研究成果: 雜誌貢獻文章

1 引文 (Scopus)

摘要

Drug repurposing aims to find novel indications of clinically used or experimental drugs. Because drug data already exist, drug repurposing may save time and cost, and bypass safety concerns. Polypharmacology, one drug with multiple targets, serves as a basis for drug repurposing. Large-scale databases have been accumulated in recent years, and utilization and integration of these databases would be highly helpful for polypharmacology and drug repurposing. The Connectivity Map (CMap) is a database collecting gene-expression profiles of drug-treated human cancer cells, which has been widely used for investigation of polypharmacology and drug repurposing. In this study, we integrated the next-generation L1000-based CMap and an analytic Web tool, the L1000FWD, for systematic analyses of polypharmacology and drug repurposing. Two different types of anti-cancer drugs were used as proof-of-concept examples, including histone deacetylase (HDAC) inhibitors and topoisomerase inhibitors. We identified KM-00927 and BRD-K75081836 as novel HDAC.
原文英語
文章編號181321
期刊Royal Society Open Science
5
發行號11
DOIs
出版狀態已發佈 - 十一月 1 2018

指紋

Polypharmacology
Drug Repositioning
Databases
Pharmaceutical Preparations
Topoisomerase Inhibitors
Histone Deacetylase Inhibitors
Histone Deacetylases
Transcriptome
Neoplasms
Safety
Costs and Cost Analysis

Keywords

  • Cancer therapy
  • Connectivity Map
  • Drug repurposing
  • Histone deacetylase
  • Polypharmacology
  • Topoisomerase

ASJC Scopus subject areas

  • General

引用此文

Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining. / Liu, Tsang Pai; Hsieh, Yao Yu; Chou, Chia Jung; Yang, Pei Ming.

於: Royal Society Open Science, 卷 5, 編號 11, 181321, 01.11.2018.

研究成果: 雜誌貢獻文章

@article{846bc0830ba441809a7d5e1d1f811d66,
title = "Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining",
abstract = "Drug repurposing aims to find novel indications of clinically used or experimental drugs. Because drug data already exist, drug repurposing may save time and cost, and bypass safety concerns. Polypharmacology, one drug with multiple targets, serves as a basis for drug repurposing. Large-scale databases have been accumulated in recent years, and utilization and integration of these databases would be highly helpful for polypharmacology and drug repurposing. The Connectivity Map (CMap) is a database collecting gene-expression profiles of drug-treated human cancer cells, which has been widely used for investigation of polypharmacology and drug repurposing. In this study, we integrated the next-generation L1000-based CMap and an analytic Web tool, the L1000FWD, for systematic analyses of polypharmacology and drug repurposing. Two different types of anti-cancer drugs were used as proof-of-concept examples, including histone deacetylase (HDAC) inhibitors and topoisomerase inhibitors. We identified KM-00927 and BRD-K75081836 as novel HDAC.",
keywords = "Cancer therapy, Connectivity Map, Drug repurposing, Histone deacetylase, Polypharmacology, Topoisomerase, Cancer therapy, Connectivity Map, Drug repurposing, Histone deacetylase, Polypharmacology, Topoisomerase",
author = "Liu, {Tsang Pai} and Hsieh, {Yao Yu} and Chou, {Chia Jung} and Yang, {Pei Ming}",
year = "2018",
month = "11",
day = "1",
doi = "10.1098/rsos.181321",
language = "English",
volume = "5",
journal = "Royal Society Open Science",
issn = "2054-5703",
publisher = "The Royal Society",
number = "11",

}

TY - JOUR

T1 - Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining

AU - Liu, Tsang Pai

AU - Hsieh, Yao Yu

AU - Chou, Chia Jung

AU - Yang, Pei Ming

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Drug repurposing aims to find novel indications of clinically used or experimental drugs. Because drug data already exist, drug repurposing may save time and cost, and bypass safety concerns. Polypharmacology, one drug with multiple targets, serves as a basis for drug repurposing. Large-scale databases have been accumulated in recent years, and utilization and integration of these databases would be highly helpful for polypharmacology and drug repurposing. The Connectivity Map (CMap) is a database collecting gene-expression profiles of drug-treated human cancer cells, which has been widely used for investigation of polypharmacology and drug repurposing. In this study, we integrated the next-generation L1000-based CMap and an analytic Web tool, the L1000FWD, for systematic analyses of polypharmacology and drug repurposing. Two different types of anti-cancer drugs were used as proof-of-concept examples, including histone deacetylase (HDAC) inhibitors and topoisomerase inhibitors. We identified KM-00927 and BRD-K75081836 as novel HDAC.

AB - Drug repurposing aims to find novel indications of clinically used or experimental drugs. Because drug data already exist, drug repurposing may save time and cost, and bypass safety concerns. Polypharmacology, one drug with multiple targets, serves as a basis for drug repurposing. Large-scale databases have been accumulated in recent years, and utilization and integration of these databases would be highly helpful for polypharmacology and drug repurposing. The Connectivity Map (CMap) is a database collecting gene-expression profiles of drug-treated human cancer cells, which has been widely used for investigation of polypharmacology and drug repurposing. In this study, we integrated the next-generation L1000-based CMap and an analytic Web tool, the L1000FWD, for systematic analyses of polypharmacology and drug repurposing. Two different types of anti-cancer drugs were used as proof-of-concept examples, including histone deacetylase (HDAC) inhibitors and topoisomerase inhibitors. We identified KM-00927 and BRD-K75081836 as novel HDAC.

KW - Cancer therapy

KW - Connectivity Map

KW - Drug repurposing

KW - Histone deacetylase

KW - Polypharmacology

KW - Topoisomerase

KW - Cancer therapy

KW - Connectivity Map

KW - Drug repurposing

KW - Histone deacetylase

KW - Polypharmacology

KW - Topoisomerase

UR - http://www.scopus.com/inward/record.url?scp=85058366266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058366266&partnerID=8YFLogxK

U2 - 10.1098/rsos.181321

DO - 10.1098/rsos.181321

M3 - Article

VL - 5

JO - Royal Society Open Science

JF - Royal Society Open Science

SN - 2054-5703

IS - 11

M1 - 181321

ER -